Vaccine Research in Australia: Landscaping capabilities and relevant services


Internationally, vaccines are one of the fastest growing sectors in the pharmaceutical and biotechnology industry. This project seeks to create a streamlined pathway for Australian vaccine development from the time of conception at the laboratory bench, typically in a University research lab, all the way through to human trials and commercialisation.

Whilst Australia has an exemplary record of basic immunology and vaccine research, there has been a major failure to capture the commercial value of this Australian research. This project will landscape the vaccine space, developing a free-to-use, publicly accessible database of all interested parties in the sector, and draw them together for the first Australian Vaccine conference in December 2017.

Visit Vaxine to learn more.

Twitter: vaxine_news

LinkedIn: Vaxine

Consortium lead Vaxine
Consortium members Mylexa Pty Ltd, Australian Respiratory and Sleep Medicine Institute Ltd
MTPConnect grant $250,000
Industry contributions $250,000
Project duration March 2017 - February 2019
Contact Sharen Pringle, Vaxine - sharen.pringle@sa.gov.au